Showing results (2121-2130 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 29, 2012
Mmp-9 inhibitors in the brain: can old bullets shoot new targets?Leszek KaczmarekCurrent Pharmaceutical Design|September 29, 2012
Dynorphin convertases and their functions in CNSJoanna Ner, Jerzy SilberringCurrent Pharmaceutical Design|September 29, 2012
Infections and atheromatous plaque: current therapeutic implicationsMarietta Charakida, Dimitris TousoulisCurrent Pharmaceutical Design|September 29, 2012
Refractory angina pectoris: lessons from the past and current perspectivesManolis Vavuranakis, Maria Kariori, Konstantinos Kalogeras, et al.Current Pharmaceutical Design|September 29, 2012
HPV pathway profiling: HPV related cervical dysplasia and carcinoma studiesSusy M Scholl, Maud Kamal, Léanne De Koning, et al.Current Pharmaceutical Design|September 29, 2012
Role of cell cycle biomarkers in human papillomavirus related uterine lesionsPablo Conesa-ZamoraCurrent Pharmaceutical Design|September 29, 2012
The immunohistochemical assessment of HPV related adenocarcinoma: pathologic and clinical prognostic significanceRaluca Balan, Irina-Draga Căruntu, Cornelia AmălineiCurrent Pharmaceutical Design|September 29, 2012
Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?Lucija Tomljenovic, Jean Pierre Spinosa, Christopher A ShawCurrent Pharmaceutical Design|September 29, 2012
Risk of cervical cancer after HPV vaccinationMaurie MarkmanCurrent Pharmaceutical Design|September 29, 2012
Prevalence and distribution of human papillomavirus genotype in south eastern Italy, in the period 2006-2011: implications for interventionMarcello Guido, Andrea Tinelli, Antonella De Donno, et al.Pageof 1,008